ArticleCancers2020
Breast Cancer Mortality among Women with a
Article in Cancers, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
13 citing papers in PubMed, 25 citations in OpenAlex.
- Harnessing genomics for early cancer detection, risk stratification and prevention.Nature genetics · 2026Review
- ESR Essentials: post-treatment breast cancer surveillance from mammography to a more personalised approach-practice recommendations by the European Society of Breast Imaging.European radiology · 2026Review
- Does the Addition of MRI Help in Breast Cancer Detection in Women with Low Breast Tissue Density in Two Canadian Population-based High-Risk Breast Screening Programs?Radiology. Imaging cancer · 2025Article
- Investigation of the relationship between fear of the pandemic and health beliefs regarding breast cancer of women between the ages of 40-69.Journal of education and health promotion · 2025Article
- Article
- Toward Application of Polygenic Risk Scores to Both Enhance and Deintensify Breast Cancer Screening.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024Article
- MRI Surveillance and Breast Cancer Mortality in Women With BRCA1 and BRCA2 Sequence Variations.JAMA oncology · 2024Article
- Choices for cancer prevention for women with a BRCA1 mutation? a personal view.Hereditary cancer in clinical practice · 2023Article
- Epidemiology of Breast Cancer Mortality in Kazakhstan, trends and Geographic Distribution.Asian Pacific journal of cancer prevention : APJCP · 2023Article
- Identification of BRCA1/2 mutation female carriers using circulating microRNA profiles.Nature communications · 2023Article
- Survival of BRCA1/BRCA2-associated pT1 breast cancer patients, a cohort study.Breast cancer research and treatment · 2022Article
- From the patient to the population: Use of genomics for population screening.Frontiers in genetics · 2022Article
- Comparison of diagnostic values of two magnetic resonance imaging (MRI) protocols for diagnosis of breast lesions.International journal of physiology, pathophysiology and pharmacology · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors at 5 institutions in 1 country.
Funding
Abstract
Annual breast magnetic resonance imaging (MRI) plus mammography is the standard of care for screening women with inherited
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.